The PICALM Protein Plays a Key Role in Iron Homeostasis and Cell Proliferation

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Scotland, Paula B ^a   Heath, Jessica L ^a   Conway, Amanda E ^a   Porter, Natasha B ^a   Armstrong, Michael B ^a   Walker, Jennifer A ^a   Klebig, Mitchell L ^b   Lavau, Catherine P ^a   Wechsler, Daniel S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; CLATHRIN ASSEMBLY PROTEIN; PHOSPHATIDYLINOSITOL BINDING CLATHRIN ASSEMBLY PROTEIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENDOCYTOSIS; FIBROBLAST; FLOW CYTOMETRY; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IRON METABOLISM; IRON TRANSPORT; MOUSE; NONHUMAN; PHENOTYPE; POINT MUTATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACIDS; ANIMALS; CELL MEMBRANE; CELL PROLIFERATION; CLATHRIN; EMBRYO, MAMMALIAN; ENDOCYTOSIS; FIBROBLASTS; GENE EXPRESSION REGULATION; HEK293 CELLS; HOMEOSTASIS; HUMANS; INTRACELLULAR SPACE; IRON; IRON CHELATING AGENTS; MICE; MONOMERIC CLATHRIN ASSEMBLY PROTEINS; PHENOTYPE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TRANSFERRIN; RNA, MESSENGER;

MURINAE; MUS;

EID: 84865594496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044252     Document Type: Article

References (61)

1. Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, et al. (1996) The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci USA 93: 4804-4809.
2. Tebar F, Bohlander SK, Sorkin A, (1999) Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell 10: 2687-2702.
3. Caudell D, Aplan PD, (2008) The role of CALM-AF10 gene fusion in acute leukemia. Leukemia 22: 678-685.
4. Meyerholz A, Hinrichsen L, Groos S, Esk P-C, Brandes G, et al. (2005) Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation. Traffic 6: 1225-1234.
5. Mettlen M, Stoeber M, Loerke D, Antonescu CN, Danuser G, et al. (2009) Endocytic accessory proteins are functionally distinguished by their differential effects on the maturation of clathrin-coated pits. Mol Biol Cell 20: 3251-3260.
6. Huang F, Khvorova A, Marshall W, Sorkin A, (2004) Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. J Biol Chem 279: 16657-16661.
7. Klebig ML, Wall MD, Potter MD, Rowe EL, Carpenter DA, et al. (2003) Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice. Proc Natl Acad Sci USA 100: 8360-8365.
8. Potter MD, Shinpock SG, Popp RA, Godfrey V, Carpenter DA, et al. (1997) Mutations in the murine fitness 1 gene result in defective hematopoiesis. Blood 90: 1850-1857.
9. Schultze AE, Schaeffer DO, Potter MD, Johnson DK, (1997) Alterations in Growth, Hematopoiesis and Serum Chemistry Profiles in fitness 14226SB Mutant Mice. Comp Hematol Int 7: 143-151.
10. Schultze AE, Poppenga RH, Johnson DK, (1998) Alterations in Serum and Tissue Iron Profiles Associated with Mutations in the fitness 14226SB Locus of Mice. Comp Hematol Int 8: 72-76.
11. Schultze AE, McEntee MF, Daniel GB, Johnson DK, (1999) Radiographic, histologic, and cytologic lesions associated with mutations in the fitness1(4226SB) locus of mice. Lab Animal Sci 49: 260-268.
12. Vecchi M, Polo S, Poupon V, van de Loo JW, Benmerah A, et al. (2001) Nucleocytoplasmic shuttling of endocytic proteins. J Cell Biol 153: 1511-1517.
13. Archangelo LF, Glasner J, Krause A, Bohlander SK, (2006) The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10. Oncogene 25: 4099-4109.
14. Bushlin I, Petralia RS, Wu F, Harel A, Mughal MR, et al. (2008) Clathrin assembly protein AP180 and CALM differentially control axogenesis and dendrite outgrowth in embryonic hippocampal neurons. J Neurosci 28: 10257-10271.
15. Petralia RS, Yao PJ, (2007) AP180 and CALM in the developing hippocampus: expression at the nascent synapse and localization to trafficking organelles. J Compar Neurol 504: 314-327.
16. Schwartz CM, Cheng A, Mughal MR, Mattson MP, Yao PJ, (2010) Clathrin assembly proteins AP180 and CALM in the embryonic rat brain. J Compar Neurol 518: 3803-3818.
17. Yao PJ, Petralia RS, Bushlin I, Wang Y, Furukawa K, (2005) Synaptic distribution of the endocytic accessory proteins AP180 and CALM. J Compar Neurol 481: 58-69.
18. Morgan JR, Zhao X, Womack M, Prasad K, Augustine GJ, et al. (1999) A role for the clathrin assembly domain of AP180 in synaptic vesicle endocytosis. J Neurosci 19: 10201-10212.
19. Kalthoff C, Alves J, Urbanke C, Knorr R, Ungewickell EJ, (2002) Unusual structural organization of the endocytic proteins AP180 and epsin 1. J Biol Chem 277: 8209-8216.
20. Ford MG, Pearse BM, Higgins MK, Vallis Y, Owen DJ, et al. (2001) Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science 291: 1051-1055.
21. Kim HL, Kim JA, (2000) Purification of clathrin assembly protein from rat liver. Exp Molec Medicine 32: 222-226.
22. Morgan JR, Prasad K, Hao W, Augustine GJ, Lafer EM, (2000) A conserved clathrin assembly motif essential for synaptic vesicle endocytosis. J Neurosci 20: 8667-8676.
23. Huh JY, Chung S, Oh D, Kang MS, Eom HS, et al. (2010) Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature. Korean J Lab Medicine 30: 117-121.
24. Wechsler DS, Engstrom LD, Alexander BM, Motto DG, Roulston D, (2003) A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein. Genes Chromosom Cancer 36: 26-36.
25. Kumon K, Kobayashi H, Maseki N, Sakashita A, Sakurai M, et al. (1999) Mixed-lineage leukemia with t(10;11)(p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features. Genes Chromosom Cancer 25: 33-39.
26. Asnafi V, Radford-Weiss I, Dastugue N, Bayle C, Leboeuf D, et al. (2003) CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood 102: 1000-1006.
27. Savage NM, Kota V, Manaloor EJ, Kulharya AS, Pierini V, et al. (2010) Acute leukemia with PICALM-MLLT10 fusion gene: diagnostic and treatment struggle. Cancer Genet Cytogenet 202: 129-132.
28. Deshpande AJ, Cusan M, Rawat VP, Reuter H, Krause A, et al. (2006) Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell 10: 363-374.
29. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genet 41: 1088-1093.
30. Nordstedt C, Caporaso GL, Thyberg J, Gandy SE, Greengard P, (1993) Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells. J Biol Chem 268: 608-612.
31. Jones L, Harold D, Williams J, (2010) Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease. Biochim Biophys Acta 1801: 754-761.
32. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, et al. (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303: 1832-1840.
33. Jun G, Naj AC, Beecham GW, Wang L-S, Buros J, et al. (2010) Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67: 1473-1484.
34. Wilson IA, Haft DH, Getzoff ED, Tainer JA, Lerner RA, et al. (1985) Identical short peptide sequences in unrelated proteins can have different conformations: a testing ground for theories of immune recognition. Proc Natl Acad Sci USA 82: 5255-5259.
35. Esposito BP, Epsztejn S, Breuer W, Cabantchik ZI, (2002) A review of fluorescence methods for assessing labile iron in cells and biological fluids. Anal Biochem 304: 1-18.
36. Kaplan J, Jordan I, Sturrock A, (1991) Regulation of the transferrin-independent iron transport system in cultured cells. The J Biol Chem 266: 2997-3004.
37. Hao W, Luo Z, Zheng L, Prasad K, Lafer EM, (1999) AP180 and AP-2 interact directly in a complex that cooperatively assembles clathrin. J Biol Chem 274: 22785-22794.
38. Harel A, Wu F, Mattson MP, Morris CM, Yao PJ, (2008) Evidence for CALM in directing VAMP2 trafficking. Traffic 9: 417-429.
39. Miller SE, Sahlender DA, Graham SC, Honing S, Robinson MS, et al. (2011) The molecular basis for the endocytosis of small R-SNAREs by the clathrin adaptor CALM. Cell 147: 1118-1131.
40. Potter MD, Klebig ML, Carpenter DA, Rinchik EM, (1995) Genetic and physical mapping of the fitness 1 (fit1) locus within the Fes-Hbb region of mouse chromosome 7. Mamm Genome 6: 70-75.
41. Suzuki M, Tanaka H, Tanimura A, Tanabe K, Oe N, et al. (2012) The Clathrin Assembly Protein PICALM Is Required for Erythroid Maturation and Transferrin Internalization in Mice. PloS one 7: e31854.
42. Casey JL, Koeller DM, Ramin VC, Klausner RD, Harford JB, (1989) Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA. EMBO J 8: 3693-3699.
43. Silliman CC, McGavran L, Wei Q, Miller LA, Li S, et al. (1998) Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides. Leukemia 12: 1404-1410.
44. Di Fiore PP, Gill GN, (1999) Endocytosis and mitogenic signaling. Curr Opin Cell Biol 11: 483-488.
45. Di Fiore PP, De Camilli P, (2001) Endocytosis and signaling. an inseparable partnership. Cell 106: 1-4.
46. Di Fiore PP, (2009) Endocytosis, signaling and cancer, much more than meets the eye. Mol Oncol 3: 273-279.
47. Hupalowska A, Miaczynska M, (2012) The new faces of endocytosis in signaling. Traffic 13: 9-18.
48. Richardson DR, Kalinowski DS, Lau S, Jansson PJ, Lovejoy DB, (2009) Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta 1790: 702-717.
49. Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ, (1992) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 31: 327-335.
50. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR, (2004) Iron, brain ageing and neurodegenerative disorders. Nature Rev Neurosci 5: 863-873.
51. Smith MA, Zhu X, Tabaton M, Liu G, McKeel DW Jr, et al. (2010) Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimer's Dis 19: 363-372.
52. Oshiro S, Morioka MS, Kikuchi M, (2011) Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Adv Pharmacol Sci 2011: 378278.
53. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, et al. (2010) Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol 67: 961-964.
54. Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, et al. (2010) Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet 19: 3295-3301.
55. Treusch S, Hamamichi S, Goodman JL, Matlack KE, Chung CY, et al. (2011) Functional Links Between Abeta Toxicity, Endocytic Trafficking, and Alzheimer's Disease Risk Factors in Yeast. Science 334(6060): 1241-1245.
56. Morita S, Kojima T, Kitamura T, (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7: 1063-1066.
57. Kingston RE, Chen CA, Okayama H (2001) Calcium phosphate transfection. Cur Protocols Immunol Chapter 10: Unit 10.13.
58. Du C, Redner RL, Cooke MP, Lavau C, (1999) Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes. Blood 94: 793-802.
59. Armbruster BN, Banik SS, Guo C, Smith AC, Counter CM, (2001) N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo. Molecular and Cell Biol 21: 7775-7786.
60. Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, et al. (2006) A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441: 106-110.
61. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nature Protocols 3: 1101-1108.